We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
-1.39%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$345M
AUM Growth
+$21M
(+6.5%)
Cap. Flow
+$33.8M
Cap. Flow
% of AUM
9.8%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
466
New
14
Increased
365
Reduced
39
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$4.2M |
| 2 |
Procter & Gamble
PG
|
+$3.18M |
| 3 |
Apple
AAPL
|
+$2.96M |
| 4 |
Booking.com
BKNG
|
+$2.81M |
| 5 |
Diageo
DEO
|
+$2.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$3.37M |
| 2 |
NVIDIA
NVDA
|
+$3.35M |
| 3 |
On Holding
ONON
|
+$2.92M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$2.64M |
| 5 |
ASML
ASML
|
+$2.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.24% |
| 2 | Consumer Discretionary | 20.57% |
| 3 | Healthcare | 19.52% |
| 4 | Communication Services | 8.19% |
| 5 | Consumer Staples | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
326
Bicycle Therapeutics
BCYC
$284M
| $13.6K | ﹤0.01% |
679
+340
| +100% | +$7.78K |
|
327
Allogene Therapeutics
ALLO
$714M
| $13.6K | ﹤0.01% |
4,297
+2,385
| +125% | +$10.5K |
|
|
HLVX
328
DELISTED
HilleVax
HLVX
| $13.6K | ﹤0.01% |
1,008
+494
| +96% | +$6.95K |
|
329
HUTCHMED
HCM
$2.13B
| $13.4K | ﹤0.01% |
792
+380
| +92% | +$5.44K |
|
330
Evolus
EOLS
$536M
| $13.3K | ﹤0.01% |
1,459
+713
| +96% | +$6.39K |
|
331
Harrow
HROW
$1.48B
| $13K | ﹤0.01% |
908
+513
| +130% | +$8.97K |
|
332
uniQure
QURE
$3.13B
| $13K | ﹤0.01% |
1,943
-17,117
| -90% | -$154K |
|
|
RPTX
333
DELISTED
Repare Therapeutics
RPTX
| $13K | ﹤0.01% |
1,079
+527
| +95% | +$5.44K |
|
334
Biomea Fusion
BMEA
$92.8M
| $12.7K | ﹤0.01% |
921
+457
| +98% | +$8.24K |
|
335
Aclaris Therapeutics
ACRS
$860M
| $12.4K | ﹤0.01% |
1,814
+888
| +96% | +$7.59K |
|
336
AnaptysBio
ANAB
$1.69B
| $12.2K | ﹤0.01% |
682
+335
| +97% | +$6.39K |
|
|
RNAM
337
DELISTED
Avidity Biosciences
RNAM
| $12.1K | ﹤0.01% |
1,895
+967
| +104% | +$8.33K |
|
338
Theravance Biopharma
TBPH
$878M
| $11.7K | ﹤0.01% |
1,357
+600
| +79% | +$5.79K |
|
339
Castle Biosciences
CSTL
$960M
| $11.6K | ﹤0.01% |
689
+339
| +97% | +$5.93K |
|
340
UroGen Pharma
URGN
$2.39B
| $10.8K | ﹤0.01% |
774
+467
| +152% | +$7.5K |
|
341
Caribou Biosciences
CRBU
$169M
| $10.8K | ﹤0.01% |
2,258
+1,453
| +180% | +$9.01K |
|
|
MRNS
342
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $10.5K | ﹤0.01% |
1,304
+642
| +97% | +$5.34K |
|
343
Scholar Rock
SRRK
$6.55B
| $10.2K | ﹤0.01% |
1,441
+729
| +102% | +$4.9K |
|
344
Nautilus Biotechnolgy
NAUT
$114M
| $10.1K | ﹤0.01% |
3,204
+1,567
| +96% | +$5.1K |
|
|
ITOS
345
DELISTED
iTeos Therapeutics
ITOS
| $10.1K | ﹤0.01% |
924
+455
| +97% | +$5.82K |
|
346
Cullinan Oncology
CGEM
$1.26B
| $9.91K | ﹤0.01% |
1,095
+579
| +112% | +$6.03K |
|
347
Nurix Therapeutics
NRIX
$2.76B
| $9.78K | ﹤0.01% |
1,244
+622
| +100% | +$5.68K |
|
348
SIGA Technologies
SIGA
$206M
| $9.56K | ﹤0.01% |
1,821
+887
| +95% | +$4.37K |
|
349
Lyell Immunopharma
LYEL
$347M
| $9.46K | ﹤0.01% |
322
+158
| +96% | +$7.5K |
|
350
Edgewise Therapeutics
EWTX
$4.73B
| $9.36K | ﹤0.01% |
1,634
+805
| +97% | +$5.47K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q3 2023 Portfolio in Review
As of Q3 2023, China Universal Asset Management Company held 466 positions worth $345M, up 6.5% from $324M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company deployed $33.8M of net new capital in Q3 2023, opening 14 new positions and adding to 365 existing holdings. Its largest new stake was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $3.37M trimmed.
- China Universal Asset Management Company's largest Q3 2023 buy was SPDR Gold MiniShares Trust: 71,700 shares worth $2.63M.
- China Universal Asset Management Company added most to Amazon in Q3 2023, an estimated $4.2M increase.
- China Universal Asset Management Company's biggest Q3 2023 reduction was TSMC, cutting an estimated $3.37M.
- China Universal Asset Management Company fully exited Carnival Corporation Ltd in Q3 2023, selling an estimated $2.64M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $345M portfolio in Q3 2023.
- China Universal Asset Management Company opened 14 new positions and closed 20 in Q3 2023.
- China Universal Asset Management Company's portfolio value rose 6.5% quarter-over-quarter to $345M.
Based on China Universal Asset Management Company's 13F filing for Q3 2023, filed 31 Oct 2023.